News & Events
Press Releases
Q1 2012
- University of California, San Diego Uses RainDance’s Technology to Detect Rare Somatic Mutations in Solid Tumors Undetectable by Current Sequencing Methods
- RainDance Technologies Teams with Hospital Saint-Louis and BGI to Confirm Mutations Associated with Rheumatoid Arthritis
- The Scientist Names RainDance ThunderStorm™ System One of the Top 10 Innovations of 2011
Q4 2011
- British Columbia Cancer Agency Selects RainDance’s New ThunderStorm™ System for High-Throughput Targeted Sequencing of Cancer Predisposition Genes
- RainDance Technologies and Ambry Genetics Launch Industry’s Most Comprehensive DNA Sequencing Panel for ADME Research
- Technology Targets Genetic Disorders Linked to X Chromosome
- RainDance Technologies Sets New Throughput and Performance Bar in Targeted Sequencing with Launch of ThunderStorm™ System
Q3 2011
- Ambry Genetics Adopts RainDance's New ThunderStorm™ System for High-Throughput Next-Generation Targeted Sequencing Services
- RainDance MethylSeq™ Solution Powers Two New Epigenetic Studies Focused on Cell Differentiation and Cancer Progression
Q2 2011
- RainDance Technologies Collaborates with Sony DADC to Commercialize Smart Consumables for Life Science Applications
- RainDance Technologies Names Andy Watson Vice President and Chief Marketing Officer
- RainDance Technologies Launches Comprehensive Genetic Screening Research Tool for Identifying Mutations Associated with Analyzing Human Immune Function and Defense
Q1 2011
- RainDance Technologies Appoints Laura Deming Senior Vice President of Product Development
- RainDance Technologies Launches Two Comprehensive Genetic Screening Research Tools for Identifying Mutations Associated with X-Chromosome and Autism Spectrum Disorders
- Roche and RainDance Technologies Join Forces in Targeted Sequencing to Advance ADME Research
- RainDance Technologies and Ambry Genetics Expand Collaboration to Address ADME Analysis
- RainDance Launches DeepSeq™ FFPE Solution for Discovery of Rare Cancer Mutations
- RainDance Technologies Raises $37.5 Million in Series D Financing
Q4 2010
- RainDance Technologies Continues Aggressive Expansion Across European Region
- RainDance’s Microdroplet Technology Recognized as a Breakthrough Invention
- RainDance’s Targeted Sequencing Approach Powers Three Groundbreaking Human Genetic Studies
- RainDance Technologies Strengthens Leadership Team with Key Appointments
- RainDance Technologies CEO Recognized For Leadership and Community Service
2012 Events
2012 Advances in Genome Biology and Technology Meeting (AGBT) |
2012 ACMG Annual Clinical Genetics Meeting |
AACR Annual Meeting 2012 |
European Human Genetics Conference 2012 |
Association for Molecular Pathology 2012 Annual Meeting |
American Society of Human Genetics Conference 2012 (ASHG) |
For technical questions contact:
James Brayer
RainDance Technologies
44 Hartwell Avenue
Lexington, MA 02421
781-861-6300
info@raindancetech.com
For press inquiries:
Colin Sanford
203-340-2441
colin@bioscribe.com
